Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Wallis

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Kidney Journal|June 14, 2016
One good match permits another-why HLA-matched blood transfusion makes senseBen C Reynolds, Sally A Johnson, Vaughan Carter, et al.
International Journal of Molecular Sciences|July 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Jonathan P Wallis, Helen Marr, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|April 13, 2013
Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant techniqueKei Yiu Douglas Hui, Stuart M Robinson, Aimen Amer, et al.
Biomedicines|July 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis, et al.
Lancet (London, England)|October 18, 2002
Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusionJonathan P Wallis, Simon Haynes, Gail Stark, et al.
International Journal of Molecular Sciences|February 11, 2023
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 InhibitionErhan Aptullahoglu, Carmela Ciardullo, Jonathan P Wallis, et al.
Cancers|January 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2015
ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titersClaire A Irving, Andrew R Gennery, Vaughan Carter, et al.
British Journal of Haematology|March 18, 2014
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemiaDeepa Jayakody Arachchillage, Erin Hurst, Peter Carey, et al.
Haematologica|April 21, 2019
Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cellsCarmela Ciardullo, Erhan Aptullahoglu, Laura Woodhouse, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Kidney Journal|June 14, 2016
One good match permits another-why HLA-matched blood transfusion makes senseBen C Reynolds, Sally A Johnson, Vaughan Carter, et al.
International Journal of Molecular Sciences|July 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Jonathan P Wallis, Helen Marr, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|April 13, 2013
Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant techniqueKei Yiu Douglas Hui, Stuart M Robinson, Aimen Amer, et al.
Biomedicines|July 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis, et al.
Lancet (London, England)|October 18, 2002
Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusionJonathan P Wallis, Simon Haynes, Gail Stark, et al.
International Journal of Molecular Sciences|February 11, 2023
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 InhibitionErhan Aptullahoglu, Carmela Ciardullo, Jonathan P Wallis, et al.
Cancers|January 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2015
ABO-incompatible cardiac transplantation in pediatric patients with high isohemagglutinin titersClaire A Irving, Andrew R Gennery, Vaughan Carter, et al.
British Journal of Haematology|March 18, 2014
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemiaDeepa Jayakody Arachchillage, Erin Hurst, Peter Carey, et al.
Haematologica|April 21, 2019
Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cellsCarmela Ciardullo, Erhan Aptullahoglu, Laura Woodhouse, et al.
Pageof 3